• Ionis Enters Collaboration with Partner to Develop IONIS-FB-LRx americanpharmaceuticalreview
    October 12, 2018
    Ionis announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leverage Ionis' leadership in RNA-targeted therapeutics to develop IONIS-FB-LRx targeting Factor B (FB) for a
PharmaSources Customer Service